Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(15):1162-1163; doi:10.1093/jnci/dji216
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kunkler, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunkler, I.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

CORRESPONDENCE

Re: Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial

Ian Kunkler

Correspondence to: Ian Kunkler, FRCR, Department of Clinical Oncology, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, United Kingdom (e-mail: i.kunkler@ed.ac.uk).

The first 10% of the full text of this article appears below.

The paper of Ragaz et al. (1) provides important level 1 evidence that the improvement in overall survival from the addition of postmastectomy radiotherapy to systemic therapy in axillary lymph node-positive patients, previously reported (2), is sustained up to 20 years.

Ragaz et al. rightly identify the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

RESPONSE: Re: Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial
Joseph Ragaz, Ivo A. Olivotto, Kenneth S. Wilson, John J. Spinelli, and Ralph Durand
J Natl Cancer Inst 2005 97: 1163-1164. [Extract] [Full Text] [PDF]